Two‐Year Safety and Efficacy of Biodegradable Polymer Drug‐Eluting Stent Versus Second‐Generation Durable Polymer Drug‐Eluting Stent in Patients With Acute Myocardial Infarction: Data from the Korea Acute Myocardial Infarction Registry (KAMIR)
ConclusionsBP‐DES and 2G‐DP‐DES appear to have comparable 2‐year safety and efficacy for the treatment of AMI. However, longer‐term follow‐up is needed.
Source: Clinical Cardiology - Category: Cardiology Authors: Seung‐Ho Hur, In‐Cheol Kim, Ki‐Bum Won, Yun‐Kyeong Cho, Hyuck‐Jun Yoon, Chang‐Wook Nam, Kwon‐Bae Kim, Min‐Seok Kim, Jincheol Park, Seung‐Woon Rha, Shung‐Chull Chae, Young‐Jo Kim, Chong‐Jin Kim, Myeong‐Chan Cho, Myung‐Ho Jeong, Tags: Clinical Investigations Source Type: research
More News: Angiography | Cardiology | Diabetes | Diabetes Mellitus | Endocrinology | Heart | Heart Attack | Thrombosis